Research graph
References from The diagnostic utility of abdominal and bowel ultrasound in detecting gastrointestinal and hepatic manifestations of rheumatoid arthritis. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
10.1111/joim.13058
10.1111/joim.13058 · External reference
Rheumatoid arthritis
10.7326/aitc201901010 · 2019 · External reference
Rheumatoid arthritis: a brief overview of the treatment
10.1159/000493390 · 2018 · External reference
Epidemiology of rheumatoid arthritis: genetic and environmental influences
10.1080/1744666x.2022.2106970 · 2022 · External reference
Gastrointestinal and hepatic disease in rheumatoid arthritis
10.1016/j.rdc.2017.09.005 · 2018 · External reference
Gastrointestinal and hepatic manifestations of rheumatoid arthritis
10.1007/s10620-010-1508-7 · 2011 · External reference
Irritable bowel syndrome and rheumatoid arthritis: prevalence, epidemiological characteristics and associated risk factors
10.14309/00000434-201810001-02784 · 2018 · External reference
The role of autoantibodies in the pathophysiology of rheumatoid arthritis
10.1007/s00281-017-0627-z · 2017 · External reference
Hepatic and gastrointestinal manifestations in rheumatic and connective tissue diseases
10.14442/jgfm.17.2_132 · 2016 · External reference
Application of ultrasound in the diagnosis of gastrointestinal tumors
10.1177/2058739220961194 · 2020 · External reference
Transabdominal ultrasonographic features in the diagnosis of gastrointestinal lymphoma
2018 · External reference
Prevalence of findings in routine abdominal ultrasound in patients with systemic autoimmune rheumatic diseases and their impact on therapeutic decision making
10.3390/app12020851 · 2022 · External reference
Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
10.1002/art.1780380107 · 1995 · External reference
Disease activity scores using C-reactive protein: CRP may replace ESR in the assessment of RA disease activity
2004 · External reference
Bowel Disorders
10.1053/j.gastro.2016.02.031 · 2016 · External reference
Development of the GerdQ, a tool for the diagnosis and management of gastro-oesophageal reflux disease in primary care
10.1111/j.1365-2036.2009.04142.x · 2009 · External reference
A validated symptoms questionnaire (Chinese GERDQ) for the diagnosis of gastro-oesophageal reflux disease in the Chinese population
10.1046/j.1365-2036.2003.01576.x · 2003 · External reference
Transabdominal sonography of the gastrointestinal tract
10.1007/s00330-001-1201-5 · 2002 · External reference
Diagnostic performance of ultrasonography in detecting fatty liver disease in comparison with Fibroscan in people suspected of fatty liver
10.4103/abr.abr_114_19 · 2019 · External reference
Extra articular manifestations in Egyptian rheumatoid arthritis patients
10.21608/ejrci.2014.10426 · 2014 · External reference
Rheumatoid arthritis study of the Egyptian College of Rheumatology (ECR): nationwide presentation and worldwide stance
2023 · External reference
Prevalence and risk factors of gastrointestinal disorders in patients with rheumatoid arthritis: results from a population-based survey in Olmsted County, Minnesota
10.1155/2011/745829 · 2011 · External reference
Brief report: assessment of mucosal barrier integrity using serological biomarkers in preclinical stages of rheumatoid arthritis
10.3389/fimmu.2023.1117742 · 2023 · External reference
Effects of disturbed sleep on gastrointestinal and somatic pain symptoms in IBS
10.1111/apt.13677 · 2016 · External reference
Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: a systematic review and meta-analysis
10.1016/s2468-1253(20)30217-x · 2020 · External reference
Evaluation of the prevalence of irritable bowel syndrome in patients with rheumatoid arthritis
10.18502/jimc.v5i4.11342 · 2022 · External reference
Gastroesophageal reflux disease in patients with rheumatoid arthritis
10.3109/14397595.2013.843749 · 2013 · External reference
Efficacy and gastrointestinal tolerability of methotrexate in late-onset rheumatoid arthritis patients: a prospective cohort study. Egyptian
2023 · External reference
Prevalence of gastroesophageal reflux disease symptoms and related factors in patients with rheumatoid arthritis
10.3164/jcbn.12-83 · 2013 · External reference
Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case–control study
10.1177/1759720x211042739 · 2021 · External reference
Complement C3 and fatty liver disease in rheumatoid arthritis patients: a cross-sectional study
10.1111/eci.12798 · 2017 · External reference
Prevalence and determinants of peripheral microvascular endothelial dysfunction in rheumatoid arthritis patients: a multicenter cross-sectional study
10.1155/2018/6548715 · 2018 · External reference
AB0486 Liver fibrosis in rheumatoid arthritis patients treated with methotrexate: hypoalbuminemia, the biological pitfall
10.1136/annrheumdis-2023-eular.6479 · 2023 · External reference
Egyptian guidelines for the treatment of rheumatoid arthritis — 2022 update
10.1186/s43166-022-00153-x · 2022 · External reference
Clinical features of liver dysfunction in collagen diseases
10.1111/j.1872-034x.2010.00707.x · 2010 · External reference
Autoimmune liver diseases in systemic rheumatic diseases
10.3748/wjg.v28.i23.2527 · 2022 · External reference
Etiological features of liver involvement in rheumatoid arthritis
10.2174/1573397115666191007121605 · 2020 · External reference
Abnormal liver function tests in inflammatory arthritis: think beyond the DMARDs
10.1093/omcr/omy058 · 2018 · External reference
Unresolved reference
2022 · External reference
Small bowel ultrasound beyond inflammatory bowel disease: an updated review of the recent literature
10.1016/j.ultrasmedbio.2017.04.028 · 2017 · External reference
